What Is Medial-Compartment Knee Osteoarthritis?

Medial-compartment knee osteoarthritis (OA) is a common form of arthritis that affects the inner side of the knee. It often causes ongoing pain and stiffness, making everyday activities like walking or standing a real challenge. This can have a major impact on a person’s quality of life. In this article, we’ll explore Arthrosamid, a new injectable treatment designed to specifically address this type of knee OA by providing better joint cushioning and symptom relief.

Understanding Why the Inner Knee Is Vulnerable

The inner part of the knee bears a lot of weight thanks to the natural alignment of the leg, which often angles slightly inward — a position referred to as varus alignment. This puts extra pressure on the medial compartment, causing the cartilage here – the slick, cushioning material – to wear away more quickly than in other parts of the knee. As this cartilage diminishes, bones start to rub together, leading to pain, stiffness, and difficulty moving, especially when bearing weight.

Why Cushioning Is Key to Managing OA

Healthy knees rely on cartilage and joint fluid to act like shock absorbers, keeping movements smooth and pain-free. When this cushioning breaks down, the joint experiences more wear and tear, which worsens the condition. This can trigger a cycle where pain limits movement, and reduced activity causes the condition to deteriorate faster. For people with added pressure on the inner knee, this loss of cushioning often means shorter walking distances and less time spent standing comfortably.

How Arthrosamid Works

Arthrosamid is an exciting development in knee OA treatment. It’s a hydrogel-based injection that acts like an artificial cushion inside the knee joint. Its gel-like nature allows it to settle into the precise area needing support – especially the medial compartment – helping restore some of the shock absorption lost through cartilage deterioration. As one study puts it, “Arthrosamid® has been known to be safe and efficacious in knee osteoarthritis (OA) patients,” offering pain relief and improvement in joint function so patients can stand and walk with greater ease.

Expert Care at the London Cartilage Clinic

The London Cartilage Clinic is well known for offering specialised treatments in cartilage health. Under the guidance of Professor Paul Lee — who brings a wealth of experience as a cartilage expert and advisor to the Royal College of Surgeons of Edinburgh — patients receive thorough assessments and tailored plans to manage their knee health. While the clinic provides detailed information on all treatments, including injections like Arthrosamid, it focuses on professional guidance rather than promoting any one procedure.

What Patients and Research Tell Us

Research into Arthrosamid is ongoing, but it is already shedding light on who is likely to benefit most. Although “the literature surrounding which patients would incur the most benefit from Arthrosamid is limited,” studies aim to “identify which patient factors would allow Arthrosamid to provide the most clinical benefit in a knee OA patient.” This highlights the value of personalised treatment—considering individual symptoms, overall health, and disease severity. Many patients report noticeable relief in pain and improved mobility, boosting quality of life and sometimes delaying the need for surgery.

Final Thoughts and Advice

Medial-compartment knee osteoarthritis can be particularly challenging due to the unique stresses placed on the inner knee joint. Arthrosamid offers a targeted, innovative approach by replacing lost cushioning with a safe injectable gel, which can help ease pain and improve movement. If you suffer from this condition, it’s vital to seek expert advice to explore the best treatment options tailored to your needs. Centres such as the London Cartilage Clinic combine expert knowledge with personalised care, ensuring you are supported every step of the way. Always consult a qualified healthcare professional before starting any new treatment.

References

• Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., Verma, T., & Lee, P. Y. F. (2025). Polyacrylamide hydrogel injections in knee osteoarthritis: A PROMs-based 24 month cohort study. Journal of Clinical Orthopaedics and Trauma, 103136. https://doi.org/10.1016/j.jcot.2025.103136
• Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., & Lee, P. Y. (2025). The impact of patient factors on the minimal clinically important difference of Arthrosamid polyacrylamide hydrogel injection for knee osteoarthritis: A cohort study. Osteoarthritis and Cartilage, 33(S1), S648. https://doi.org/10.1016/j.joca.2025.02.648